Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERENUMAB-AOOE Cause Injury associated with device? 528 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 528 reports of Injury associated with device have been filed in association with ERENUMAB-AOOE. This represents 1.1% of all adverse event reports for ERENUMAB-AOOE.

528
Reports of Injury associated with device with ERENUMAB-AOOE
1.1%
of all ERENUMAB-AOOE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Injury associated with device From ERENUMAB-AOOE?

Of the 528 reports, 3 (0.6%) required hospitalization.

Is Injury associated with device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERENUMAB-AOOE. However, 528 reports have been filed with the FAERS database.

What Other Side Effects Does ERENUMAB-AOOE Cause?

Accidental exposure to product (9,923) Device difficult to use (9,530) Wrong technique in product usage process (9,359) Drug dose omission by device (6,340) Migraine (4,290) Drug ineffective (3,813) Constipation (3,104) Product storage error (2,958) Headache (2,787) Injection site pain (2,715)

What Other Drugs Cause Injury associated with device?

COPPER (2,895) ADALIMUMAB (2,003) EVOLOCUMAB (1,326) INSULIN GLARGINE (849) INSULIN LISPRO (840) TIRZEPATIDE (836) ETANERCEPT (743) DULAGLUTIDE (482) ENOXAPARIN (458) INTERFERON BETA-1A (421)

Which ERENUMAB-AOOE Alternatives Have Lower Injury associated with device Risk?

ERENUMAB-AOOE vs ERENUMAB\ERENUMAB-AOOE ERENUMAB-AOOE vs ERGOCALCIFEROL ERENUMAB-AOOE vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL ERENUMAB-AOOE vs ERIBULIN ERENUMAB-AOOE vs ERLOTINIB

Related Pages

ERENUMAB-AOOE Full Profile All Injury associated with device Reports All Drugs Causing Injury associated with device ERENUMAB-AOOE Demographics